COMP <GO>
LONA vs ELOX // OPERATING MARGIN
LeonaBio Inc. (NASDAQ) VS. Eloxx Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: LONA 1
— ELOX 2
■ METRIC PARITY
LAST: $4.73 (-4.25%) • MKT CAP: $46.5M
operating-margins
—
LAST: $12.84 (-4.53%) • MKT CAP: $54.3M
operating-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LONA VS. ELOX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LONA | ELOX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -11.87% | — | TIE | /fcf-yield <GO> |
| Operating Margin ACTIVE | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 1/9 | +1.00 | LONA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.9 | 45.4 | -1.50 | ELOX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $46.5M | $54.3M | -$7.7M | ELOX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LONA REV | ELOX REV | LONA GROSS % | ELOX GROSS % | LONA FCF | ELOX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $286.3M | $18.0M | — | — | -$45.7M | -$6.3M |
| FY 2024 | $282.5M | $6.4M | — | — | -$97.2M | -$4.7M |
| FY 2023 | $351.3M | $48.4M | — | — | -$100.8M | -$14.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LONA // BETA —
ELOX // BETA —